RXQ Compounding LLC is recalling 395 vials of Lidocaine 1% + Epinephrine 1:100,000 Injection Solution because testing revealed the product is sub-potent, meaning it is weaker than labeled. The recall affects 50 mL glass vials of this prescription medication, which is used for local anesthesia during medical procedures. If the medication is sub-potent, it may not provide the necessary level of numbing, potentially leading to pain during a procedure or requiring additional doses. Consumers who may have received this medication should contact their healthcare provider or pharmacist for guidance.
A sub-potent local anesthetic may fail to effectively numb the treatment area during a medical procedure, causing the patient to experience unexpected pain or discomfort. Additionally, a lower-than-intended dose of epinephrine could affect the medication's ability to control bleeding or prolong the anesthetic effect.
Contact your healthcare provider or pharmacist for guidance.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.